Jose Miguel
Rivera Caravaca
Profesor Permanente Laboral
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (7)
2022
-
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465
-
Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry
European Journal of Clinical Investigation, Vol. 52, Núm. 4
-
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 2, pp. 202-210
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
2021
-
Relationship between multimorbidity and outcomes in atrial fibrillation
Experimental Gerontology, Vol. 153
2018
-
Quality of oral anticoagulation with Vitamin K antagonists in 'real-world' patients with atrial fibrillation: A report from the prospective multicentre FANTASIIA registry
Europace, Vol. 20, Núm. 9, pp. 1435-1441
-
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry
Thrombosis and Haemostasis, Vol. 118, Núm. 2, pp. 279-287